Largest biotech companies by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Amgen leads the 24 biotech companies ranked by cash on hand, at MX$172.2B, ahead of BioNTech (MX$160.6B) and Gilead Sciences (MX$142.6B). Figures as of 18 Nov 2026, 22:51 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenMX$172.2B
Median
MX$8.2B
Combined market value
MX$15.77T
Countries
5

Market values as of .

All countries
All sectors
Biotech
MXN
Clear filters
Largest biotech companies by cash on hand
#CompanyCash on hand ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareMX$172.2BMX$4.53TMX$8,370.92 3.07% down 34% up United States
2BioNTechBNTX · Health CareMX$160.6BMX$389.3BMX$1,570.13 1.89% down 16% down Germany
3Gilead SciencesGILD · Health CareMX$142.6BMX$3.95TMX$3,186.64 0.75% down 33% up United States
4argenxARGX · Health CareMX$65.8BMX$1.12TMX$17,750.19 0.66% down 4% up Belgium
5BiogenBIIB · Health CareMX$56.7BMX$700.8BMX$4,741.11 0.25% up 49% up United States
6ModernaMRNA · Health CareMX$48.9BMX$1.5TMX$3,711.09 4.84% down 755% up United States
7ImmunovantIMVT · Health CareMX$17BMX$129.5BMX$625.52 0.12% down 43% up United States
8QiagenQGEN · Health CareMX$15.8BMX$193BMX$934.61 0.38% down 12% up Netherlands
9Neurocrine BiosciencesNBIX · Health CareMX$13.4BMX$310.9BMX$3,071.23 1.84% down 20% up United States
10RepligenRGEN · Health CareMX$10.7BMX$208.2BMX$3,256.23 6.47% up 5% up United States
11Krystal BiotechKRYS · Health CareMX$9.4BMX$176.2BMX$5,946.71 5.62% up 46% up United States
12ExelixisEXEL · Health CareMX$9.1BMX$314.2BMX$1,287.82 0.31% down 63% up United States
13Revolution MedicinesRVMD · Health CareMX$7.2BMX$651.9BMX$3,013.90 1.76% down 131% up United States
14Kymera TherapeuticsKYMR · Health CareMX$6.7BMX$195BMX$2,284.28 0.32% down 87% up United States
15CRISPR TherapeuticsCRSP · Health CareMX$6.6BMX$73.5BMX$757.91 0.10% up 21% down Switzerland
16Scholar Rock HoldingSRRK · Health CareMX$6.1BMX$110.4BMX$905.19 6.48% up 14% up United States
17Bio-TechneTECH · Health CareMX$5BMX$215.5BMX$1,371.93 0.17% up 26% up United States
18Kodiak SciencesKOD · Health CareMX$4BMX$120.6BMX$1,844.51 1.04% up 396% up United States
19Twist BioscienceTWST · Health CareMX$3.5BMX$149.6BMX$2,194.14 3.88% up 340% up United States
20VaxcytePCVX · Health CareMX$3.3BMX$174.7BMX$1,103.58 1.48% down 22% up United States
21Halozyme TherapeuticsHALO · Health CareMX$2.5BMX$206BMX$1,806.61 0.18% down 37% up United States
22ImmunityBioIBRX · Health CareMX$1.7BMX$134.4BMX$126.35 7.03% up 193% up United States
23Adaptive BiotechnologiesADPT · Health CareMX$1.3BMX$86.9BMX$536.70 0.11% down 88% up United States
24CG OncologyCGON · Health CareMX$612.7MMX$134.8BMX$1,508.65 1.34% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 18.8581 MXN).

Questions and answers

Which biotech companies rank first by cash on hand?

Amgen (MX$172.2B), BioNTech (MX$160.6B) and Gilead Sciences (MX$142.6B) are the top three of the 24 biotech companies ranked by cash on hand as of 18 Nov 2026, 22:51 UTC.

How many biotech companies are in this ranking?

24 are ranked by cash on hand.

What are these biotech companies worth together?

The 24 biotech companies ranked by cash on hand have a combined market value of MX$15.77T as of 18 Nov 2026, 22:51 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.